Chimeric Antigen Receptor Cell Therapy Market Report

1 Report Overview

• 1.1 Product Definition and Scope

• 1.2 PEST (Political, Economic, Social and Technological) Analysis of Chimeric Antigen Receptor Cell Therapy Market

• 1.3 Market Segmentation by Type

• 1.3.1 Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Monotherapy from 2014 to 2026

• 1.3.2 Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Combination Therapy from 2014 to 2026

• 1.4 Market Segmentation by End-Users

• 1.4.1 Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Acute Leukemia from 2014 to 2026

• 1.4.2 Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Non-hodgkin's Lymphoma from 2014 to 2026

• 1.4.3 Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Multiple Myeloma from 2014 to 2026

• 1.4.4 Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Transplant Rejection from 2014 to 2026

• 1.4.5 Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Other from 2014 to 2026

• 1.5 Market Segmentation by Regions

• 1.5.1 North America Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.1.1 United States Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.1.2 Canada Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.1.3 Mexico Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.2 Europe Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.2.1 Germany Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.2.2 UK Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.2.3 France Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.2.4 Italy Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.2.5 Nordic Countries Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.2.6 Spain Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.2.7 Belgium Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.2.8 Poland Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.2.9 Russia Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.2.10 Turkey Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.3 Asia-Pacific Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.3.1 China Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.3.2 Japan Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.3.3 Australia and New Zealand Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.3.4 India Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.3.5 ASEAN Countries Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.3.6 South Korea Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.4 Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.4.1 GCC Countries Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.4.2 Brazil Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.4.3 Nigeria Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.4.4 South Africa Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

• 1.5.4.5 Argentina Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

• 2.1 Market Trends and Dynamics

• 2.1.1 Market Challenges and Restraints 

• 2.1.2 Market Opportunities and Potentials

• 2.1.3 Mergers and Acquisitions

• 2.2 Competitive Landscape Analysis

• 2.2.1 Industrial Concentration Analysis

• 2.2.2 Porter's Five Forces Analysis of the Industry

• 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Chimeric Antigen Receptor Cell Therapy Market by Types

• 3.1 Product Development Trends of Different Types

• 3.2 Commercial Product Types of Major Vendors

• 3.3 Competitive Landscape Analysis of Different Types

• 3.4 Market Size of Chimeric Antigen Receptor Cell Therapy by Major Types

• 3.4.1 Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Monotherapy

• 3.4.2 Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Combination Therapy

4 Segmentation of Chimeric Antigen Receptor Cell Therapy Market by End-Users

• 4.1 Downstream Client Analysis by End-Users

• 4.2 Competitive Landscape Analysis of Different End-Users

• 4.3 Market Potential Analysis of Different End-Users

• 4.4 Market Size of Chimeric Antigen Receptor Cell Therapy by Major End-Users

• 4.4.1 Market Size and Growth Rate of Chimeric Antigen Receptor Cell Therapy in Acute Leukemia

• 4.4.2 Market Size and Growth Rate of Chimeric Antigen Receptor Cell Therapy in Non-hodgkin's Lymphoma

• 4.4.3 Market Size and Growth Rate of Chimeric Antigen Receptor Cell Therapy in Multiple Myeloma

• 4.4.4 Market Size and Growth Rate of Chimeric Antigen Receptor Cell Therapy in Transplant Rejection

• 4.4.5 Market Size and Growth Rate of Chimeric Antigen Receptor Cell Therapy in Other

5 Market Analysis by Major Regions

• 5.1 Global Chimeric Antigen Receptor Cell Therapy Production Analysis by Major Regions

• 5.2 Global Chimeric Antigen Receptor Cell Therapy Consumption Analysis by Major Regions

• 5.3 Global Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export Analysis by Regions

• 5.3.1 North America Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export Analysis 

• 5.3.2 Europe Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export Analysis

• 5.3.3 Asia Pacific Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export Analysis

• 5.3.4 Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export Analysis

6 Product Commodity of Chimeric Antigen Receptor Cell Therapy Market in Major Countries

• 6.1 Top 5 Export Countries in Chimeric Antigen Receptor Cell Therapy market from 2014 to 2019

• 6.1.1 Top 5 Export Countries' Export Value Analysis in Chimeric Antigen Receptor Cell Therapy market from 2014 to 2019

• 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Chimeric Antigen Receptor Cell Therapy market from 2014 to 2019

• 6.2 Top 5 Import Countries in Chimeric Antigen Receptor Cell Therapy market from 2014 to 2019

• 6.2.1 Top 5 Import Countries' Import Value Analysis in Chimeric Antigen Receptor Cell Therapy market from 2014 to 2019

• 6.2.2 Top 5 Import Countries' Import Volume Analysis in Chimeric Antigen Receptor Cell Therapy market from 2014 to 2019

• 6.3 Emerging Top 3 Export Countries Analysis

• 6.4 Emerging Top 3 Import Countries Analysis

7 North America Chimeric Antigen Receptor Cell Therapy Landscape Analysis

• 7.1 North America Chimeric Antigen Receptor Cell Therapy Landscape Analysis by Major Types

• 7.2 North America Chimeric Antigen Receptor Cell Therapy Landscape Analysis by Major End-Users

• 7.3 North America Chimeric Antigen Receptor Cell Therapy Landscape Analysis by Major Countries

• 7.3.1 United States Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 7.3.2 Canada Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 7.3.3 Mexico Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

8 Europe Chimeric Antigen Receptor Cell Therapy Landscape Analysis

• 8.1 Europe Chimeric Antigen Receptor Cell Therapy Landscape Analysis by Major Types

• 8.2 Europe Chimeric Antigen Receptor Cell Therapy Landscape Analysis by Major End-Users

• 8.3 Europe Chimeric Antigen Receptor Cell Therapy Landscape Analysis by Major Countries

• 8.3.1 Germany Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 8.3.2 UK Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 8.3.3 France Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 8.3.4 Italy Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 8.3.5 Nordic Countries Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 8.3.6 Spain Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 8.3.7 Belgium Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 8.3.8 Poland Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 8.3.9 Russia Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 8.3.10 Turkey Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

9 Asia Pacific Chimeric Antigen Receptor Cell Therapy Landscape Analysis

• 9.1 Asia Pacific Chimeric Antigen Receptor Cell Therapy Landscape Analysis by Major Types

• 9.2 Asia Pacific Chimeric Antigen Receptor Cell Therapy Landscape Analysis by Major End-Users

• 9.3 Asia Pacific Chimeric Antigen Receptor Cell Therapy Landscape Analysis by Major Countries

• 9.3.1 China Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 9.3.2 Japan Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 9.3.3 Australia and New Zealand Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 9.3.4 India Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 9.3.5 ASEAN Countries Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 9.3.6 South Korea Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

10 Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Landscape Analysis

• 10.1 Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Landscape Analysis by Major Types

• 10.2 Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Landscape Analysis by Major End-Users

• 10.3 Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Landscape Analysis by Major Countries

• 10.3.1 GCC Countries Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 10.3.2 Brazil Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 10.3.3 Nigeria Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

• 10.3.4 South Africa Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate 

• 10.3.5 Argentina Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate

11 Major Players Profile

• 11.1 Hebei Senlang Biotechnology Inc Ltd

• 11.1.1 Hebei Senlang Biotechnology Inc Ltd Company Profile and Recent Development

• 11.1.2 Market Performance

• 11.1.3 Product and Service Introduction

• 11.2 Amgen Inc

• 11.2.1 Amgen Inc Company Profile and Recent Development

• 11.2.2 Market Performance

• 11.2.3 Product and Service Introduction

• 11.3 Gilead Sciences Inc

• 11.3.1 Gilead Sciences Inc Company Profile and Recent Development

• 11.3.2 Market Performance

• 11.3.3 Product and Service Introduction

• 11.4 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

• 11.4.1 Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd Company Profile and Recent Development

• 11.4.2 Market Performance

• 11.4.3 Product and Service Introduction

• 11.5 Celyad SA

• 11.5.1 Celyad SA Company Profile and Recent Development

• 11.5.2 Market Performance

• 11.5.3 Product and Service Introduction

• 11.6 bluebird bio Inc

• 11.6.1 bluebird bio Inc Company Profile and Recent Development

• 11.6.2 Market Performance

• 11.6.3 Product and Service Introduction

• 11.7 Takara Bio Inc

• 11.7.1 Takara Bio Inc Company Profile and Recent Development

• 11.7.2 Market Performance

• 11.7.3 Product and Service Introduction

• 11.8 Ono Pharmaceutical Co Ltd

• 11.8.1 Ono Pharmaceutical Co Ltd Company Profile and Recent Development

• 11.8.2 Market Performance

• 11.8.3 Product and Service Introduction

• 11.9 Daiichi Sankyo Co Ltd

• 11.9.1 Daiichi Sankyo Co Ltd Company Profile and Recent Development

• 11.9.2 Market Performance

• 11.9.3 Product and Service Introduction

• 11.10 Beijing Immunochina Medical Science & Technology Co Ltd

• 11.10.1 Beijing Immunochina Medical Science & Technology Co Ltd Company Profile and Recent Development

• 11.10.2 Market Performance

• 11.10.3 Product and Service Introduction

• 11.11 Bellicum Pharmaceuticals Inc

• 11.11.1 Bellicum Pharmaceuticals Inc Company Profile and Recent Development

• 11.11.2 Market Performance

• 11.11.3 Product and Service Introduction

• 11.12 Juno Therapeutics Inc

• 11.12.1 Juno Therapeutics Inc Company Profile and Recent Development

• 11.12.2 Market Performance

• 11.12.3 Product and Service Introduction

• 11.13 NantKwest Inc

• 11.13.1 NantKwest Inc Company Profile and Recent Development

• 11.13.2 Market Performance

• 11.13.3 Product and Service Introduction

• 11.14 Nkarta Inc

• 11.14.1 Nkarta Inc Company Profile and Recent Development

• 11.14.2 Market Performance

• 11.14.3 Product and Service Introduction

• 11.15 Celularity Inc

• 11.15.1 Celularity Inc Company Profile and Recent Development

• 11.15.2 Market Performance

• 11.15.3 Product and Service Introduction

• 11.16 Fosun Pharmaceutical AG

• 11.16.1 Fosun Pharmaceutical AG Company Profile and Recent Development

• 11.16.2 Market Performance

• 11.16.3 Product and Service Introduction

• 11.17 Cell Medica Ltd

• 11.17.1 Cell Medica Ltd Company Profile and Recent Development

• 11.17.2 Market Performance

• 11.17.3 Product and Service Introduction

• 11.18 CARsgen Therapeutics Ltd

• 11.18.1 CARsgen Therapeutics Ltd Company Profile and Recent Development

• 11.18.2 Market Performance

• 11.18.3 Product and Service Introduction

• 11.19 HRAIN Biotechnology Co Ltd

• 11.19.1 HRAIN Biotechnology Co Ltd Company Profile and Recent Development

• 11.19.2 Market Performance

• 11.19.3 Product and Service Introduction

• 11.20 Cellular Biomedicine Group Inc

• 11.20.1 Cellular Biomedicine Group Inc Company Profile and Recent Development

• 11.20.2 Market Performance

• 11.20.3 Product and Service Introduction

• 11.21 Nanjing Legend Biotech Co Ltd

• 11.21.1 Nanjing Legend Biotech Co Ltd Company Profile and Recent Development

• 11.21.2 Market Performance

• 11.21.3 Product and Service Introduction

• 11.22 Celgene Corp

• 11.22.1 Celgene Corp Company Profile and Recent Development

• 11.22.2 Market Performance

• 11.22.3 Product and Service Introduction

• 11.23 Kite Pharma Inc

• 11.23.1 Kite Pharma Inc Company Profile and Recent Development

• 11.23.2 Market Performance

• 11.23.3 Product and Service Introduction

• 11.24 Novartis AG

• 11.24.1 Novartis AG Company Profile and Recent Development

• 11.24.2 Market Performance

• 11.24.3 Product and Service Introduction

• 11.25 Autolus Therapeutics Plc

• 11.25.1 Autolus Therapeutics Plc Company Profile and Recent Development

• 11.25.2 Market Performance

• 11.25.3 Product and Service Introduction

• 11.26 Sorrento Therapeutics Inc

• 11.26.1 Sorrento Therapeutics Inc Company Profile and Recent Development

• 11.26.2 Market Performance

• 11.26.3 Product and Service Introduction

• 11.27 Bristol-Myers Squibb Co

• 11.27.1 Bristol-Myers Squibb Co Company Profile and Recent Development

• 11.27.2 Market Performance

• 11.27.3 Product and Service Introduction

• 11.28 Hangzhou Converd Co Ltd

• 11.28.1 Hangzhou Converd Co Ltd Company Profile and Recent Development

• 11.28.2 Market Performance

• 11.28.3 Product and Service Introduction

• 11.29 Guangzhou Anjie Biomedical Technology Co Ltd

• 11.29.1 Guangzhou Anjie Biomedical Technology Co Ltd Company Profile and Recent Development

• 11.29.2 Market Performance

• 11.29.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 102 Figures and 152 Tables)

• Figure Product Picture

• Figure Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Monotherapy from 2014 to 2026

• Figure Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Combination Therapy from 2014 to 2026

• Figure Market Share by Type in 2014

• Figure Market Share by Type in 2018

• Figure Market Share by Type in 2026

• Figure Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Acute Leukemia from 2014 to 2026

• Figure Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Non-hodgkin's Lymphoma from 2014 to 2026

• Figure Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Multiple Myeloma from 2014 to 2026

• Figure Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Transplant Rejection from 2014 to 2026

• Figure Global Chimeric Antigen Receptor Cell Therapy Market Size and Growth Rate of Other from 2014 to 2026

• Figure Market Share by End-User in 2014

• Figure Market Share by End-User in 2018

• Figure Market Share by End-User in 2026

• Figure North America Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure United States Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Canada Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Mexico Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Europe Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Germany Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure UK Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure France Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Italy Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Nordic Countries Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Spain Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Belgium Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Poland Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Russia Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Turkey Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Asia-Pacific Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure China Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Japan Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Australia and New Zealand Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure India Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure ASEAN Countries Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure South Korea Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure GCC Countries Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Brazil Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Nigeria Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure South Africa Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Argentina Chimeric Antigen Receptor Cell Therapy Consumption Market Size and Growth Rate from 2014 to 2026

• Figure Development Trends and Industry Dynamics of Chimeric Antigen Receptor Cell Therapy Industry

• Figure Market Challenges and Restraints

• Figure Market Opportunities and Potentials

• Table Mergers and Acquisition

• Figure Market Share of TOP 3 Players in 2018

• Figure Market Share of TOP 5 Players in 2018

• Figure Market Share of TOP 6 Players from 2014 to 2019

• Figure Porter's Five Forces Analysis

• Figure New Entrant SWOT Analysis

• Table Specifications of Different Types of Chimeric Antigen Receptor Cell Therapy

• Figure Development Trends of Different Types

• Table Commercial Products Types of Major Vendors

• Figure Competitive Landscape Analysis of Different Types

• Table Consumption of Chimeric Antigen Receptor Cell Therapy by Different Types from 2014 to 2026

• Table Consumption Share of Chimeric Antigen Receptor Cell Therapy by Different Types from 2014 to 2026

• Figure Market Size and Growth Rate of Monotherapy

• Figure Market Size and Growth Rate of Combination Therapy

• Table Downstream Client Analysis by End-Users

• Figure Competitive Landscape Analysis of Different End-Users

• Table Market Potential Analysis of Different End-Users

• Table Consumption of Chimeric Antigen Receptor Cell Therapy by Different End-Users from 2014 to 2026

• Table Consumption Share of Chimeric Antigen Receptor Cell Therapy by Different End-Users from 2014 to 2026

• Figure Market Size and Growth Rate of Acute Leukemia

• Figure Market Size and Growth Rate of Non-hodgkin's Lymphoma

• Figure Market Size and Growth Rate of Multiple Myeloma

• Figure Market Size and Growth Rate of Transplant Rejection

• Figure Market Size and Growth Rate of Other

• Table Global Chimeric Antigen Receptor Cell Therapy Production by Major Regions

• Table Global Chimeric Antigen Receptor Cell Therapy Production Share by Major Regions

• Figure Global Chimeric Antigen Receptor Cell Therapy Production Share by Major Regions in 2014

• Figure Global Chimeric Antigen Receptor Cell Therapy Production Share by Major Regions in 2018

• Figure Global Chimeric Antigen Receptor Cell Therapy Production Share by Major Regions in 2026

• Table Global Chimeric Antigen Receptor Cell Therapy Consumption by Major Regions

• Table Global Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Regions

• Figure Global Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Regions in 2014

• Figure Global Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Regions in 2018

• Figure Global Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Regions in 2026

• Table North America Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export Analysis

• Table Europe Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export Analysis

• Table Asia Pacific Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export Analysis

• Table Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Production, Import, Consumption and Export Analysis

• Table Top 5 Export Countries' Export Value Analysis in Chimeric Antigen Receptor Cell Therapy market from 2014 to 2019

• Table Top 5 Export Countries' Export Volume Analysis in Chimeric Antigen Receptor Cell Therapy market from 2014 to 2019

• Table Top 5 Import Countries' Import Value Analysis in Chimeric Antigen Receptor Cell Therapy market from 2014 to 2019

• Table Top 5 Import Countries' Import Volume Analysis in Chimeric Antigen Receptor Cell Therapy market from 2014 to 2019

• Figure Emerging Top 3 Export Countries Analysis

• Figure Emerging Top 3 Import Countries Analysis

• Table North America Chimeric Antigen Receptor Cell Therapy Consumption by Types from 2014 to 2026

• Table North America Chimeric Antigen Receptor Cell Therapy Consumption Share by Types from 2014 to 2026

• Figure North America Chimeric Antigen Receptor Cell Therapy Consumption Share by Types in 2014

• Figure North America Chimeric Antigen Receptor Cell Therapy Consumption Share by Types in 2018

• Figure North America Chimeric Antigen Receptor Cell Therapy Consumption Share by Types in 2026

• Table North America Chimeric Antigen Receptor Cell Therapy Consumption by End-Users from 2014 to 2026

• Table North America Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users from 2014 to 2026

• Figure North America Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users in 2014

• Figure North America Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users in 2018

• Figure North America Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users in 2026

• Table North America Chimeric Antigen Receptor Cell Therapy Consumption by Major Countries from 2014 to 2026

• Table North America Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries from 2014 to 2026

• Figure North America Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries in 2014

• Figure North America Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries in 2018

• Figure North America Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries in 2026

• Figure United States Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure Canada Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure Mexico Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Table Europe Chimeric Antigen Receptor Cell Therapy Consumption by Types from 2014 to 2026

• Table Europe Chimeric Antigen Receptor Cell Therapy Consumption Share by Types from 2014 to 2026

• Figure Europe Chimeric Antigen Receptor Cell Therapy Consumption Share by Types in 2014

• Figure Europe Chimeric Antigen Receptor Cell Therapy Consumption Share by Types in 2018

• Figure Europe Chimeric Antigen Receptor Cell Therapy Consumption Share by Types in 2026

• Table Europe Chimeric Antigen Receptor Cell Therapy Consumption by End-Users from 2014 to 2026

• Table Europe Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users from 2014 to 2026

• Figure Europe Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users in 2014

• Figure Europe Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users in 2018

• Figure Europe Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users in 2026

• Table Europe Chimeric Antigen Receptor Cell Therapy Consumption by Major Countries from 2014 to 2026

• Table Europe Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries from 2014 to 2026

• Figure Europe Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries in 2014

• Figure Europe Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries in 2018

• Figure Europe Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries in 2026

• Figure Germany Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure UK Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure France Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure Italy Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure Nordic Countries Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure Belgium Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure Poland Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure Russia Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure Turkey Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Table Asia Pacific Chimeric Antigen Receptor Cell Therapy Consumption by Types from 2014 to 2026

• Table Asia Pacific Chimeric Antigen Receptor Cell Therapy Consumption Share by Types from 2014 to 2026

• Figure Asia Pacific Chimeric Antigen Receptor Cell Therapy Consumption Share by Types in 2014

• Figure Asia Pacific Chimeric Antigen Receptor Cell Therapy Consumption Share by Types in 2018

• Figure Asia Pacific Chimeric Antigen Receptor Cell Therapy Consumption Share by Types in 2026

• Table Asia Pacific Chimeric Antigen Receptor Cell Therapy Consumption by End-Users from 2014 to 2026

• Table Asia Pacific Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users from 2014 to 2026

• Figure Asia Pacific Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users in 2014

• Figure Asia Pacific Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users in 2018

• Figure Asia Pacific Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users in 2026

• Table Asia Pacific Chimeric Antigen Receptor Cell Therapy Consumption by Major Countries from 2014 to 2026

• Table Asia Pacific Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries from 2014 to 2026

• Figure Asia Pacific Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries in 2014

• Figure Asia Pacific Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries in 2018

• Figure Asia Pacific Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries in 2026

• Figure China Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure Japan Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure Australia and New ZealandChimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure India Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure ASEAN Countries Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure South Korea Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Table Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption by Types from 2014 to 2026

• Table Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption Share by Types from 2014 to 2026

• Figure Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption Share by Types in 2014

• Figure Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption Share by Types in 2018

• Figure Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption Share by Types in 2026

• Table Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption by End-Users from 2014 to 2026

• Table Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users from 2014 to 2026

• Figure Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users in 2014

• Figure Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users in 2018

• Figure Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption Share by End-Users in 2026

• Table Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption by Major Countries from 2014 to 2026

• Table Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries from 2014 to 2026

• Figure Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries in 2014

• Figure Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries in 2018

• Figure Latin America, Middle East & Africa Chimeric Antigen Receptor Cell Therapy Consumption Share by Major Countries in 2026

• Figure GCC Countries Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure Brazil Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure Nigeria Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure South Africa Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Figure Argentina Chimeric Antigen Receptor Cell Therapy Market Volume and Growth Rate from 2014 to 2026

• Table Company Profile and Development Status of Hebei Senlang Biotechnology Inc Ltd

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hebei Senlang Biotechnology Inc Ltd

• Figure Sales and Growth Rate Analysis of Hebei Senlang Biotechnology Inc Ltd

• Figure Revenue and Market Share Analysis of Hebei Senlang Biotechnology Inc Ltd

• Table Product and Service Introduction of Hebei Senlang Biotechnology Inc Ltd

• Table Company Profile and Development Status of Amgen Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen Inc

• Figure Sales and Growth Rate Analysis of Amgen Inc

• Figure Revenue and Market Share Analysis of Amgen Inc

• Table Product and Service Introduction of Amgen Inc

• Table Company Profile and Development Status of Gilead Sciences Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Gilead Sciences Inc

• Figure Sales and Growth Rate Analysis of Gilead Sciences Inc

• Figure Revenue and Market Share Analysis of Gilead Sciences Inc

• Table Product and Service Introduction of Gilead Sciences Inc

• Table Company Profile and Development Status of Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

• Figure Sales and Growth Rate Analysis of Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

• Figure Revenue and Market Share Analysis of Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

• Table Product and Service Introduction of Shanghai Unicar-Therapy Bio-Medicine Technology Co Ltd

• Table Company Profile and Development Status of Celyad SA

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celyad SA

• Figure Sales and Growth Rate Analysis of Celyad SA

• Figure Revenue and Market Share Analysis of Celyad SA

• Table Product and Service Introduction of Celyad SA

• Table Company Profile and Development Status of bluebird bio Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of bluebird bio Inc

• Figure Sales and Growth Rate Analysis of bluebird bio Inc

• Figure Revenue and Market Share Analysis of bluebird bio Inc

• Table Product and Service Introduction of bluebird bio Inc

• Table Company Profile and Development Status of Takara Bio Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takara Bio Inc

• Figure Sales and Growth Rate Analysis of Takara Bio Inc

• Figure Revenue and Market Share Analysis of Takara Bio Inc

• Table Product and Service Introduction of Takara Bio Inc

• Table Company Profile and Development Status of Ono Pharmaceutical Co Ltd

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ono Pharmaceutical Co Ltd

• Figure Sales and Growth Rate Analysis of Ono Pharmaceutical Co Ltd

• Figure Revenue and Market Share Analysis of Ono Pharmaceutical Co Ltd

• Table Product and Service Introduction of Ono Pharmaceutical Co Ltd

• Table Company Profile and Development Status of Daiichi Sankyo Co Ltd

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daiichi Sankyo Co Ltd

• Figure Sales and Growth Rate Analysis of Daiichi Sankyo Co Ltd

• Figure Revenue and Market Share Analysis of Daiichi Sankyo Co Ltd

• Table Product and Service Introduction of Daiichi Sankyo Co Ltd

• Table Company Profile and Development Status of Beijing Immunochina Medical Science & Technology Co Ltd

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Beijing Immunochina Medical Science & Technology Co Ltd

• Figure Sales and Growth Rate Analysis of Beijing Immunochina Medical Science & Technology Co Ltd

• Figure Revenue and Market Share Analysis of Beijing Immunochina Medical Science & Technology Co Ltd

• Table Product and Service Introduction of Beijing Immunochina Medical Science & Technology Co Ltd

• Table Company Profile and Development Status of Bellicum Pharmaceuticals Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bellicum Pharmaceuticals Inc

• Figure Sales and Growth Rate Analysis of Bellicum Pharmaceuticals Inc

• Figure Revenue and Market Share Analysis of Bellicum Pharmaceuticals Inc

• Table Product and Service Introduction of Bellicum Pharmaceuticals Inc

• Table Company Profile and Development Status of Juno Therapeutics Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics Inc

• Figure Sales and Growth Rate Analysis of Juno Therapeutics Inc

• Figure Revenue and Market Share Analysis of Juno Therapeutics Inc

• Table Product and Service Introduction of Juno Therapeutics Inc

• Table Company Profile and Development Status of NantKwest Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of NantKwest Inc

• Figure Sales and Growth Rate Analysis of NantKwest Inc

• Figure Revenue and Market Share Analysis of NantKwest Inc

• Table Product and Service Introduction of NantKwest Inc

• Table Company Profile and Development Status of Nkarta Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nkarta Inc

• Figure Sales and Growth Rate Analysis of Nkarta Inc

• Figure Revenue and Market Share Analysis of Nkarta Inc

• Table Product and Service Introduction of Nkarta Inc

• Table Company Profile and Development Status of Celularity Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celularity Inc

• Figure Sales and Growth Rate Analysis of Celularity Inc

• Figure Revenue and Market Share Analysis of Celularity Inc

• Table Product and Service Introduction of Celularity Inc

• Table Company Profile and Development Status of Fosun Pharmaceutical AG

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Fosun Pharmaceutical AG

• Figure Sales and Growth Rate Analysis of Fosun Pharmaceutical AG

• Figure Revenue and Market Share Analysis of Fosun Pharmaceutical AG

• Table Product and Service Introduction of Fosun Pharmaceutical AG

• Table Company Profile and Development Status of Cell Medica Ltd

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cell Medica Ltd

• Figure Sales and Growth Rate Analysis of Cell Medica Ltd

• Figure Revenue and Market Share Analysis of Cell Medica Ltd

• Table Product and Service Introduction of Cell Medica Ltd

• Table Company Profile and Development Status of CARsgen Therapeutics Ltd

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of CARsgen Therapeutics Ltd

• Figure Sales and Growth Rate Analysis of CARsgen Therapeutics Ltd

• Figure Revenue and Market Share Analysis of CARsgen Therapeutics Ltd

• Table Product and Service Introduction of CARsgen Therapeutics Ltd

• Table Company Profile and Development Status of HRAIN Biotechnology Co Ltd

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of HRAIN Biotechnology Co Ltd

• Figure Sales and Growth Rate Analysis of HRAIN Biotechnology Co Ltd

• Figure Revenue and Market Share Analysis of HRAIN Biotechnology Co Ltd

• Table Product and Service Introduction of HRAIN Biotechnology Co Ltd

• Table Company Profile and Development Status of Cellular Biomedicine Group Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellular Biomedicine Group Inc

• Figure Sales and Growth Rate Analysis of Cellular Biomedicine Group Inc

• Figure Revenue and Market Share Analysis of Cellular Biomedicine Group Inc

• Table Product and Service Introduction of Cellular Biomedicine Group Inc

• Table Company Profile and Development Status of Nanjing Legend Biotech Co Ltd

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nanjing Legend Biotech Co Ltd

• Figure Sales and Growth Rate Analysis of Nanjing Legend Biotech Co Ltd

• Figure Revenue and Market Share Analysis of Nanjing Legend Biotech Co Ltd

• Table Product and Service Introduction of Nanjing Legend Biotech Co Ltd

• Table Company Profile and Development Status of Celgene Corp

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celgene Corp

• Figure Sales and Growth Rate Analysis of Celgene Corp

• Figure Revenue and Market Share Analysis of Celgene Corp

• Table Product and Service Introduction of Celgene Corp

• Table Company Profile and Development Status of Kite Pharma Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kite Pharma Inc

• Figure Sales and Growth Rate Analysis of Kite Pharma Inc

• Figure Revenue and Market Share Analysis of Kite Pharma Inc

• Table Product and Service Introduction of Kite Pharma Inc

• Table Company Profile and Development Status of Novartis AG

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis AG

• Figure Sales and Growth Rate Analysis of Novartis AG

• Figure Revenue and Market Share Analysis of Novartis AG

• Table Product and Service Introduction of Novartis AG

• Table Company Profile and Development Status of Autolus Therapeutics Plc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Autolus Therapeutics Plc

• Figure Sales and Growth Rate Analysis of Autolus Therapeutics Plc

• Figure Revenue and Market Share Analysis of Autolus Therapeutics Plc

• Table Product and Service Introduction of Autolus Therapeutics Plc

• Table Company Profile and Development Status of Sorrento Therapeutics Inc

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sorrento Therapeutics Inc

• Figure Sales and Growth Rate Analysis of Sorrento Therapeutics Inc

• Figure Revenue and Market Share Analysis of Sorrento Therapeutics Inc

• Table Product and Service Introduction of Sorrento Therapeutics Inc

• Table Company Profile and Development Status of Bristol-Myers Squibb Co

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb Co

• Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb Co

• Figure Revenue and Market Share Analysis of Bristol-Myers Squibb Co

• Table Product and Service Introduction of Bristol-Myers Squibb Co

• Table Company Profile and Development Status of Hangzhou Converd Co Ltd

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hangzhou Converd Co Ltd

• Figure Sales and Growth Rate Analysis of Hangzhou Converd Co Ltd

• Figure Revenue and Market Share Analysis of Hangzhou Converd Co Ltd

• Table Product and Service Introduction of Hangzhou Converd Co Ltd

• Table Company Profile and Development Status of Guangzhou Anjie Biomedical Technology Co Ltd

• Table Sales, Revenue, Sales Price and Gross Margin Analysis of Guangzhou Anjie Biomedical Technology Co Ltd

• Figure Sales and Growth Rate Analysis of Guangzhou Anjie Biomedical Technology Co Ltd

• Figure Revenue and Market Share Analysis of Guangzhou Anjie Biomedical Technology Co Ltd

• Table Product and Service Introduction of Guangzhou Anjie Biomedical Technology Co Ltd